Intelligent Ultrasound Group (IUG) Share Price, News & Analysis

Company Overview

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams: Simulation Real-time hi-fidelity ultrasound education and training through simulation. Our main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid-19 module and the new BabyWorks Neonate and Paediatric training simulator. To date over 1,450 simulators have been sold to over 700 medical institutions around the world. Clinical AI software Deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare's SonoLyst software that is incorporated in their Voluson Expert 22 and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies ultrasound image interpretation by providing the user with real-time AI-based anatomy highlighting for a range of ultrasound guided regional anesthesia procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.

Key Stats

• Today's Range: 12.75 to 12.78
• 50-Day Range: 10.57 to 13
• 52-Week Range: 6.50 to 14.54
• Volume: 60,616 shs
• Average Volume: 122,988 shs
• Market Capitalization: £41.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IUG Stock Analysis - Frequently Asked Questions

How have IUG shares performed this year?

Intelligent Ultrasound Group's stock was trading at GBX 12.70 at the start of the year. Since then, IUG stock has increased by 0.6% and is now trading at GBX 12.78.
View the best growth stocks for 2025 here.

How do I buy shares of Intelligent Ultrasound Group?

Shares of IUG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Intelligent Ultrasound Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Ultrasound Group investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), Intel (INTC) and IQE (IQE).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: LON:IUG
• CUSIP: N/A
• CIK: N/A
• Web: www.intelligentultrasound.com
• Phone: 44 2920 756 534
• Fax: N/A
• Employees: 65
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 129.49
• P/E Growth: N/A
• Net Income: £-3,430,000.00
• Net Margins: -33.78%
• Pretax Margin: N/A
• Return on Equity: -36.19%
• Return on Assets: -13.51%

Debt

• Debt-to-Equity Ratio: 7.14
• Current Ratio: 1.43
• Quick Ratio: 2.87

Sales & Book Value

• Annual Sales: £9.88 million
• Price / Sales: 4.23
• Cash Flow: GBX 1.79 per share
• Price / Cash Flow: 7.15
• Book Value: GBX 2 per share
• Price / Book: 6.39

Miscellaneous

• Outstanding Shares: 327,040,000
• Free Float: N/A
• Market Cap: £41.80 million
• Optionable: Not Optionable
• Beta: 0.38